6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
30m ago	Rubenstein Public Relations Announces New Mining Client, Copper Intelligence
30m ago	Aegis Critical Energy Defence Corp. Confirms Spin-Out Ratio and Completion of Plan of Arrangement with Greentech Hydrogen Innovations Corp.
55m ago	Tejon Ranch Co. and Dedeaux Properties to Break Ground on 510,000-Square-Foot Industrial Facility, Signaling Confidence in Southern California’s Tightening Supply Market
56m ago	Aduro Clean Technologies Inc. To Present at The LD Micro Invitational XVI
58m ago	Revised Filing Does Not Address Competitive Balance Issues Created By UP-NS Merger

About

Dyne Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Dyne Therapeutics Announces Upcoming Presentation Highlighting Robust CNS Activity in Nonhuman Primates with its FORCE™ Platform at 2026 ASGCT Annual Meeting

Dyne Therapeutics Announces Participation at 2026 Academy of Managed Care Pharmacy (AMCP) Conference to Begin Shaping Access in US for Potential Neuromuscular Medicines

Dyne Therapeutics Announces Initiation of Phase 3 HARMONIA Trial of Z-Basivarsen in Myotonic Dystrophy Type 1 (DM1)

Dyne Therapeutics Announces New Positive Cardiopulmonary Results from DELIVER Trial of Z-Rostudirsen in Duchenne Muscular Dystrophy (DMD)

Dyne Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

How Dyne Therapeutics, Inc. runs its investor program on 6ix — audience, formats, and program overview.

Recent Videos

Duchenne Muscular Dystrophy Advances

Duchenne Muscular Dystrophy Advances

Apr 04, 2026

Neuroscience Update – 18 Mar 2026: Phase 3 HARMONIA in DM1, Roche ApoE4 CE Mark and More

Neuroscience Update – 18 Mar 2026: Phase 3 HARMONIA in DM1, Roche ApoE4 CE Mark and More

Mar 18, 2026

DYN, Dyne Therapeutics, Inc., 2026-03-10, stock prices dynamics, stock of the day

DYN, Dyne Therapeutics, Inc., 2026-03-10, stock prices dynamics, stock of the day

Mar 11, 2026

DYN, Dyne Therapeutics, Inc., 2026-03-09, stock prices dynamics, stock of the day

DYN, Dyne Therapeutics, Inc., 2026-03-09, stock prices dynamics, stock of the day

Mar 10, 2026

Community Chat

Ask AI